Science
Mechanism of Action
Nipradilol functions dually as a non-selective beta-adrenergic receptor blocker and a nitric oxide (NO) donor. As a beta-blocker, it mitigates the effects of adrenaline and noradrenaline, leading to outcomes such as decreased heart rate, reduced myocardial contractility, and vasodilation, thereby lowering blood pressure. As an NO donor, it facilitates vasodilation by relaxing vascular smooth muscle, enhancing blood flow and reducing vascular resistance. Nitric oxide also exhibits anti-inflammatory and anti-thrombotic properties. In ocular applications, the NO-donating action is understood to reduce intraocular pressure by improving aqueous humor outflow. However, there is no specific information or research on Nipradilol's mechanism of action directly on skin for cosmetic benefits.
Research
Clinical Evidence
Low confidence0.25%
Key findings
- 01 Topical administration of 0.25% Nipradilol in human subjects significantly reduced intraocular pressure (IOP) by a maximum of 4.2 mmHg, with effects lasting up to 12 hours. It also led to a 20% decrease in the aqueous flow rate in the treated eye.
- 02 In an 8-week clinical trial, 0.25% Nipradilol, applied twice daily, effectively decreased IOP in patients with ocular hypertension without developing tachyphylaxis. A comparative study demonstrated that 0.25% Nipradilol exhibited comparable efficacy and safety to 0.5% Timolol in reducing IOP in patients with primary open-angle glaucoma or ocular hypertension over the same duration.
- 03 Rabbit studies indicated a dose-dependent reduction in intraocular pressure with topical Nipradilol at concentrations of 0.125% or higher, with 0.25% achieving a near-maximal effect.
Transparency
Dusting Analysis
Nipradilol is a regulated pharmaceutical agent, not an ingredient typically incorporated into cosmetic formulations. Consequently, there is no established common usage, dusting threshold, or red-flag percentage relevant to cosmetic applications.
The Formula
Formulation
Stability
Specific formulation data, including optimal pH range for stability or general stability notes for Nipradilol as a skincare ingredient, are not available in the provided research.
Safety
Safety Profile
Nipradilol is a pharmaceutical agent and has not undergone safety review by cosmetic regulatory bodies such as the Cosmetic Ingredient Review (CIR) or the Scientific Committee on Consumer Safety (SCCS). While the FDA does not mandate pre-market approval for cosmetic ingredients, information pertaining to Nipradilol's use as a drug highlights potential side effects, including eye discomfort (burning, stinging, itching), blurred vision, dizziness, fatigue, headache, shortness of breath, decreased heart rate or blood pressure, and rare allergic reactions. It is contraindicated in individuals with severe bradycardia, advanced heart block, bronchial asthma, hypersensitivity to beta-blockers, or severe hepatic impairment. These significant drug-related risks indicate a high potential for adverse reactions if applied topically to the skin, with no corresponding cosmetic safety assessment.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Nipradilol is a pharmaceutical agent lacking any demonstrated cosmetic benefits or safety assessments for topical skin application, and its use carries significant potential health risks due to its pharmacological activity and contraindications.
Related
Similar Ingredients
Finding similar ingredients…